相关临床试验
35
5 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1997
进行中（未招募）
2
5.7%
已完成
20
57.1%
Enrolling By Invitation
2
5.7%
尚未招募
1
2.9%
招募中
2
5.7%
暂停
1
2.9%
终止
4
11.4%
撤回
3
8.6%
暂无批准数据
- MaineHealth Lincoln Hospital will transition inpatient Labor and Delivery services to MaineHealth Mid Coast Hospital effective December 18, 2026, while preserving comprehensive prenatal and postpartum care locally. - The MaineHealth Board of Trustees committed to no additional Labor and Delivery closures across the health system for the next two years and called for statewide policy collaboration. - More than two-thirds of pregnant patients in Lincoln County already deliver at hospitals other than Lincoln Hospital, with birth volumes expected to decline further. - The regional model aims to address persistent staffing challenges that prevented safe, reliable 24-hour obstetrical coverage at Lincoln Hospital.
- MaineHealth received a five-year, $1.1 million NIH grant to research how childhood PFAS exposure influences obesity, diabetes risk, and cardiovascular health later in life. - The grant supports mentorship of junior investigators pursuing careers in environmental health research, addressing Maine's disproportionate burden of PFAS contamination. - Research will examine cumulative PFAS exposure from the prenatal period through adolescence and whether healthy diet and physical activity may mitigate associated health effects. - The project leverages long-standing collaborations with large national research cohorts and builds on ongoing studies led by Principal Investigator Dr. Abby Fleisch.
- MaineHealth is doubling enrollment to 60 patients in the second year of a five-year, $20.7 million NIH-funded study on post-treatment Lyme disease syndrome. - The research aims to determine why 5% to 20% of Lyme patients develop chronic symptoms including fatigue, cognitive difficulties, and joint pain. - Scientists will investigate bacterial strain differences, immune response, genetics, and potential biomarkers as drivers of persistent illness. - The study ensures all participants have confirmed Lyme diagnoses, addressing a key limitation of prior research where patient infection status was uncertain.
- MaineHealth secured $2 million from the Maine Technology Institute to create the state's first Clinical Research Unit, a 5,500-square-foot facility at Maine Medical Center Biddeford scheduled to open in 2027. - The dedicated research facility will enable 20-40 patients in its first year to participate in clinical trials closer to home, eliminating the need to travel to Boston for certain studies. - The unit will focus on common Maine conditions including oncology, cardiovascular disease, infectious disease, and mental health, featuring observation rooms for overnight stays and dedicated pharmacy services. - The facility represents a strategic investment in Maine's life sciences infrastructure, providing early-career researchers with expanded opportunities while improving health equity for rural communities.
- MaineHealth is participating in two NIH RECOVER-ENERGIZE clinical trials testing interventions for long COVID symptoms, with enrollment continuing through July 2025 at their Scarborough research site. - The first trial evaluates personalized cardiopulmonary rehabilitation for exercise intolerance, while the second tests structured pacing for post-exertional malaise (PEM), addressing two of the most debilitating long COVID symptoms. - As one of 50 RECOVER study sites nationwide, MaineHealth's research aims to develop effective treatments for long COVID symptoms that significantly impact patients' quality of life.
